Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.9168
-0.0832 (-8.32%)
At close: Dec 1, 2025, 4:00 PM EST
0.9249
+0.0081 (0.88%)
After-hours: Dec 1, 2025, 7:31 PM EST
Werewolf Therapeutics Employees
Werewolf Therapeutics had 46 employees as of December 31, 2024. The number of employees decreased by 1 or -2.13% compared to the previous year.
Employees
46
Change (1Y)
-1
Growth (1Y)
-2.13%
Revenue / Employee
n/a
Profits / Employee
-$1,583,500
Market Cap
44.50M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 46 | -1 | -2.13% |
| Dec 31, 2023 | 47 | 1 | 2.17% |
| Dec 31, 2022 | 46 | 7 | 17.95% |
| Dec 31, 2021 | 39 | 15 | 62.50% |
| Dec 31, 2020 | 24 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HOWL News
- 24 days ago - Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting - GlobeNewsWire
- 27 days ago - Werewolf Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer - GlobeNewsWire
- 2 months ago - Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting - GlobeNewsWire
- 3 months ago - Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Werewolf Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit - GlobeNewsWire
- 6 months ago - Werewolf Therapeutics to Participate in the BIO International Convention - GlobeNewsWire